Searched for
THERAPEUTIC VALUE
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...09 Jun, 2026, 07.34 PM IST- GSK in talks to buy cancer biotech Nuvalent for more than $9 billionBritish drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...09 Jun, 2026, 11.45 AM IST
- Psychology says people who still reread old group chats from years ago share these 3 emotional reflection patternsDiving into old group chats is like flipping through a scrapbook of memories, revealing pieces of the person we used to be. These digital i...08 Jun, 2026, 03.39 PM IST
- Kiran Mazumdar-Shaw's Immuneel Therapeutics raises Rs 100 crore from Singularity AMC, Rainmatter, othersThe Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a ...08 Jun, 2026, 01.27 PM IST
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...04 Jun, 2026, 09.43 PM IST
- Weather swings, monsoon risks, and the growing threat to mango, apple cropsThe agriculture industry has evolved historically through adaptation and resilience, and now it is time to speed up this transformation, em...01 Jun, 2026, 11.43 AM IST
- IPO Calendar: Investors to get 2 mainboard public offers this week after a month of lullIndia’s IPO market is set to revive with two mainboard issues, CMR Green Technologies and Hexagon Nutrition, opening this week after a lull...31 May, 2026, 09.23 AM IST
- Sir H.N. Reliance Foundation Hospital Claims Top Spot In Nationwide Critical Care SurveySir H.N. Reliance Foundation Hospital has been ranked the country's leading multi-specialty institution in the Times of India Critical Care...30 May, 2026, 05.40 PM IST
- Psychology suggests the grandparent who tells the same family stories isn't losing the thread. Their autobiographical memory helps people keep a life coherentGrandparents often repeat family stories at dinner, a practice psychologists say is vital for preserving identity and making sense of life....28 May, 2026, 02.09 PM IST
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...24 May, 2026, 04.23 PM IST
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...23 May, 2026, 10.24 PM IST
- Siemens eyes exit from cancer care chain American Oncology InstituteSiemens Healthineers is exiting its Indian cancer care chain, American Oncology Institute. The deal is valued between ₹1,500-2,000 crore. P...14 May, 2026, 01.00 AM IST
- Quote of the Day by Sigmund Freud: 'It is impossible to escape the impression that people…'—Inspiring quotes by the Austrian neurologist and the founder of psychoanalysisQuote of the Day: Sigmund Freud, a pioneer in psychology, questioned societal values. His quote highlights how people often pursue power, s...13 May, 2026, 05.07 PM IST
- EQT emerges sole bidder for OmniActive Health TechnologiesSwedish investment powerhouse EQT is now leading the charge as the exclusive bidder for OmniActive Health Technologies, following the rejec...09 May, 2026, 09.57 AM IST
- US market today: Biotech firm Odyssey hits nearly $900 million valuation as shares rise in Nasdaq debutOdyssey Therapeutics debuted on Nasdaq with an 11.1% surge, reaching a $899.9 million valuation. The autoimmune disease specialist successf...09 May, 2026, 12.02 AM IST
- Biocon shifts focus to margins, capacity utilisation after expansion phaseBiocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...08 May, 2026, 10.19 PM IST
- Bayer to buy Perfuse Therapeutics in up to $2.45 billion dealBayer is set to acquire Perfuse Therapeutics in a deal valued up to $2.45 billion. This strategic move aims to enhance Bayer's eye care tre...06 May, 2026, 01.18 PM IST
Load More
